Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Restraint, Physical × 1 year × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 3 Uterine Cervical Dysplasia 2 Sarcoma 2 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Xeroderma Pigmentosum 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Pilonidal Sinus 1 Peritoneal Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neurofibroma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematopoietic and Lymphatic System Neoplasm 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 HIV Infections 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡